SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-18-161627
Filing Date
2018-05-14
Accepted
2018-05-14 08:02:31
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d586966dsctota.htm SC TO-T/A 36563
2 EX-(A)(1)(O) d586966dex99a1o.htm EX-99.(A)(1)(O) 19992
3 EX-(A)(1)(P) d586966dex99a1p.htm EX-99.(A)(1)(P) 13066
4 GRAPHIC g586966exa.jpg GRAPHIC 5816
5 GRAPHIC g586966snap2.jpg GRAPHIC 5762
  Complete submission text file 0001193125-18-161627.txt   87555
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address TECHNOLOGIEPARK 21 ZWIJNAARDE GHENT C9 9052
Business Address TECHNOLOGIEPARK 21 ZWIJNAARDE GHENT C9 9052 003292620000
Ablynx NV (Subject) CIK: 0001617582 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-90201 | Film No.: 18828715
SIC: 2836 Biological Products, (No Diagnostic Substances)